---
figid: PMC6266939__cancers-10-00422-g001
figtitle: Main components of the Hippo pathway and the current Hippo-targeted inhibitors
  discussed in this review
organisms:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Lareunionomyces loeiensis
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC6266939
filename: cancers-10-00422-g001.jpg
figlink: /pmc/articles/PMC6266939/figure/cancers-10-00422-f001/
number: F1
caption: 'Main components of the Hippo pathway and the current Hippo-targeted inhibitors
  discussed in this review. In mammals, the canonical Hippo pathway consists of four
  core components that function through phosphorylation: MST, SAV1, LATS, MOB1. Activated
  LATS phosphorylates YAP/TAZ, preventing them from entering the nucleus by anchoring
  them to 14-3-3 protein and/or promoting their degradation in the cytoplasm. This
  interrupts their interactions with the transcription factor TEAD family proteins,
  which subsequently inhibits cell proliferation and oncogenic transformation and
  induces apoptosis. Besides, current Hippo-targeted inhibitors discussed in this
  review, as well as their targets and major mechanisms, are shown in the figure.'
papertitle: Targeting the Hippo Pathway for Breast Cancer Therapy.
reftext: Liqing Wu, et al. Cancers (Basel). 2018 Nov;10(11):422.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9411814
figid_alias: PMC6266939__F1
figtype: Figure
redirect_from: /figures/PMC6266939__F1
ndex: f648a2c8-df04-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6266939__cancers-10-00422-g001.html
  '@type': Dataset
  description: 'Main components of the Hippo pathway and the current Hippo-targeted
    inhibitors discussed in this review. In mammals, the canonical Hippo pathway consists
    of four core components that function through phosphorylation: MST, SAV1, LATS,
    MOB1. Activated LATS phosphorylates YAP/TAZ, preventing them from entering the
    nucleus by anchoring them to 14-3-3 protein and/or promoting their degradation
    in the cytoplasm. This interrupts their interactions with the transcription factor
    TEAD family proteins, which subsequently inhibits cell proliferation and oncogenic
    transformation and induces apoptosis. Besides, current Hippo-targeted inhibitors
    discussed in this review, as well as their targets and major mechanisms, are shown
    in the figure.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Raf
  - Ilk
  - sav
  - mst
  - hpo
  - Mst84Dd
  - Mst84Dc
  - Mst84Db
  - Mst84Da
  - CG12279
  - Mst87F
  - Mst98Cb
  - Mst98Ca
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - fipi
  - Mob2
  - mats
  - wts
  - Rok
  - Pld
  - Act5C
  - 14-3-3zeta
  - 14-3-3epsilon
  - yki
  - Taz
  - Dis3
  - SNF4Agamma
  - AMPKalpha
  - Cdk1
  - sd
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - ILK
  - SAV1
  - MAP3K10
  - MPST
  - TAM
  - MSTO1
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - CXCL10
  - MOB4
  - MOB1A
  - SGMS1
  - MOB1B
  - LATS1
  - LATS2
  - ROCK1
  - ROCK2
  - GPLD1
  - PLD1
  - PLD2
  - PLD3
  - PLD4
  - PLD5
  - PLD6
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - YES1
  - YWHAQ
  - YAP1
  - TAFAZZIN
  - WWTR1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - AMOT
  - CDK1
  - TEAD1
  - TEAD2
  - TEAD3
  - TEAD4
  - Zhx2
  - Sav1
  - Stk3
  - Msto1
  - Mpst
  - Map3k10
  - Rho
  - Rhod
  - Ea2
  - Cxcl10
  - Mobq1
  - Mob1a
  - Yes1
  - Sfn
  - Yap1
  - Tafazzin
  - Wwtr1
  - Amot
  - ilk
  - sav1
  - msto1
  - hnf1ba
  - rnd2
  - mob1bb
  - lats1
  - tafazzin
  - amot
  - cdk1
  - H
  - QLT0267
  - Y27632
  - CAY10594
  - Dasatinib
  - Metformin
  - Auranofin
  - Pazopanib
  - BAY1238097
  - Verteporfin
---
